American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
 Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–752.
 Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumors. Nature. 2012;490(7418):61-70.
 Huber KE, Carey LA, Wazer DE. Breast cancer molecular subtype in patients with locally advanced disease: impact on prognosis, pattern of recurrence, and response to therapy. Semin Radiat Oncol. 2009;19(4):204-210.
 Goldhirsch A, Wood WC, Coates AS, et al. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011. Ann Oncol. 2011;22(8):1736-1747.
 Partridge SC, Nissan N, Rahbar H, Kitsch AE, Sigmund EE. Diffusion-weighted breast MRI: Clinical applications and emerging techniques. J Magn Reson Imaging 2017;45(2):337–355.
 Amornsiripanitch N, Bickelhaupt S, Shin HJ, et al. Diffusion-weighted MRI for Unenhanced Breast Cancer Screening.Radiology. 2019 Dec;293(3):504-520.
 Yang X, Dong M, Li S, et al. Diffusion-weighted imaging or dynamic contrast-enhanced curve: a retrospective analysis of contrast-enhanced magnetic resonance imaging-based differential diagnoses of benign and malignant breast lesions.Eur Radiol. 2020 Apr 29. doi: 10.1007/s00330-020-06883-w.
 Fliedner FP, Engel TB, El-Ali HH, et al.Diffusion weighted magnetic resonance imaging (DW-MRI) as a non-invasive, tissue cellularity marker to monitor cancer treatment response.BMC Cancer. 2020 Feb 19;20(1):134.
 Partridge SC, Zhang Z, Newitt DC, et al. Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial. Radiology. 2018;289(3):618‐627.
 Gillies RJ, Kinahan PE, Hricak H. Radiomics: Images Are More than Pictures, They Are Data. Radiology. 2016;278(2):563-577.
 Yip SS, Aerts HJ. Applications and limitations of radiomics. Phys Med Biol. 2016; 61(13): R150-166.
 Wang J, Kato F, Oyama-Manabe N, et al. Identifying triple-negative breast cancer using background parenchymal enhancement heterogeneity on dynamic contrast-enhanced MRI: a pilot radiomics study. PLoS One. 2015;10(11):e0143308.
 Li H, Zhu Y, Burnside ES, et al. Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. NP J Breast Cancer. 2016; 2.pii:16012.
 Li H, Zhu Y, Burnside ES, et al. MR imaging radiomics signatures for predictions the risk of breast cancer recurrence as given by research version of mammaprint, oncotype DX, and PAM50 gene assays. Radiology. 2016;281(2):382-391.
 Braman NM, Etesami M, Prasanna P, et al. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI. Breast Cancer Res. 2017; 19(1):57.
 Ma W, Zhao Y, Ji Y, et al. Breast cancer molecular subtype prediction by mammographic radiomic features. Acad Radiol. 2018; S1076-6322(18):30052-30057.
 Pinker K, Chin J, Melsaether AN, et al. Precision Medicine and Radiogenomics in Breast Cancer: New Approaches toward Diagnosis and Treatment. Radiology. 2018;287(3):732-747.
 Grimm LJ, Mazurowski MA. Breast Cancer Radiogenomics: Current Status and Future Directions. Acad Radiol. 2020;27(1):39-46.
 Yeh AC, Li H, Zhu Y, et al. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling. Cancer Imaging. 2019;19(1):48.
 Fan M, Xia P, Liu B, et al. Tumour heterogeneity revealed by unsupervised decomposition of dynamic contrast-enhanced magnetic resonance imaging is associated with underlying gene expression patterns and poor survival in breast cancer patients. Breast Cancer Res. 2019;21(1):112.
 Gallivanone F, Cava C, Corsi F, et al. In Silico Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis. Int J Mol Sci. 2019;20(23):5825.
 Zhu Z, Albadawy E, Saha A, et al. Deep Learning for Identifying Radiogenomic Associations in Breast Cancer. Comput Biol Med. 2019;109:85-90.
 Grimm LJ, Zhang J, Mazurowski MA. Computational Approach to Radiogenomics of Breast Cancer: Luminal A and Luminal B Molecular Subtypes Are Associated With Imaging Features on Routine Breast MRI Extracted Using Computer Vision Algorithms. J Magn Reson Imaging. 2015;42(4):902-7.
 Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784-2795.
 Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997-4013.
 Cheang MCU, Chia SK, Voduc D, et al. Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer. J Natl Cancer Inst. 2009;101(10):736-750.
 Dadgostar M, Tabrizi P R, Fatemizadeh E, et al. Feature Extraction Using Gabor-Filter and Recursive Fisher Linear Discriminant with Application in Fingerprint Identification. Seventh International Conference on Advances in Pattern Recognition, ICAPR 2009, pp. 217–220.
 Barnes SE, Peter M, Hoffmann L, et al. Application of generalized linear filters in data analysis. Journal of Statistical Physics. 1994;76:679-701.
 Peng H Y, Jiang C F, Fang X, et al. Variable selection for Fisher linear discriminant analysis using the modified sequential backward selection algorithm for the microarray data. Applied Mathematics & Computation. 2014; 238(7):132-140.
 Volpe V, Manzoni S, Marani M, Katul G. Leave-One-Out Cross-Validation; Springer: Berlin, Germany, 2011.
 Cohen G, Hilario M, Geissbuhler A. Model Selection for Support Vector Classifiers via Genetic Algorithms. An Application to Medical Decision Support. Lecture Notes in Computer Science, pp. 200–211, 2004.
 DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.Biometrics. 1988 sep;44(3):837-45.
 Sah RG, Agrwal K, Sharma U, et al. Characterization of malignant breast tissue of breast cancer patients and the normal breast tissue of healthy lactating women volunteers using diffusion MRI and in vivo 1H MR spectroscopy. J Magn Reson Imaging. 2015;41(1):169-174.
 Cabuk G, Nass Duce M, Özgür A, et al. The diagnostic value of diffusion-weighted imaging and the apparent diffusion coefficient values in the differentiation of benign and malignant breast lesions. J Med Imaging Radiat Oncol. 2015;59(2):141-148.
 Fujimoto H, Kazama T, Nagashima T, et al. Diffusion-weighted imaging reflects pathological therapeautic response and relapse in breast cancer. Breast Cancer. 2014;21(6):724-731.
 Liu S, Ren R, Chen Z, et al. Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy. J Magn Reson Imaging. 2015;42(3):779-787.
 Dong Y, Feng Q, Yang W, et al. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol. 2018;28(2):582-591.
 Bickelhauht S, Paech D, Kickingereder P, et al. Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography. J Magn Reson Imaging. 2017;46(2):604-616.
 Martincich L, Deantoni V, Bertotto I, et al. Correlations between diffusion-weighted imaging and breast cancer biomarkers. Eur Radiol. 2012;22(7):1519-1528.
 Grimm LJ, Zhang J, Mazurowski MA. Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms. J Magn Reson Imaging. 2015;42(4):902-907.
 Waugh SA, Purdie CA, Jordan LB, et al. Magnetic resonance imaging texture analysis classification of primary breast cancer. Eur Radiol. 2016;26(2):322-330.
 Mazuroski MA, Zhang J, Grimm LJ, et al. Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Radiology. 2014;273(2):365-372.
 Leithner D, Bernard-Davila B, Martinez DF, et al. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes. Mol Imaging Biol. 2020;22(2):453-461.
 Xie T, Wang Z, Zhao Q, et al. Machine Learning-Based Analysis of MR Multiparametric Radiomics for the Subtype Classification of Breast Cancer. Front Oncol. 2019;9:505.
 Leithner D, Mayerhoefer ME, Martinez DF, et al. Non-Invasive Assessment of Breast Cancer Molecular Subtypes with Multiparametric Magnetic Resonance Imaging Radiomics. J Clin Med. 2020;9(6):1853.
 Guo W, Li H, Zhu Y, et al. Prediction of clinical phenotype in invasive breast carcinomas from the integration of radiomics and genomics data. J Med Imaging (Bellingham). 2015;2(4):041007.